journal article·2017-12

Effect of chloride ions in Tris buffer solution on bioactive glass apatite mineralization

Gloria Kirste, Juliane Brandt‐Slowik, Christian Bocker, Michael Steinert, Reinhard Geiss, Delia S. Brauer

Publisher page

Abstract

Abstract Degradation and apatite precipitation of Bioglass 45S5 were characterized in two different tris(hydroxymethyl)aminomethane (Tris) buffer solutions. In the conventional one, pH was adjusted to 7.4 using hydrochloric acid (Tris‐HCl buffer). In the other one, acetic acid was used instead, thereby obtaining a Tris buffer solution, which was virtually free of chloride ions (Tris‐ HA c). EDX results showed that chloride ions present in Tris‐ HC l buffer solution were incorporated into the apatite formed during immersion experiments, forming a (partially) substituted chlorapatite. No chloride ions were detected in apatite precipitated in Tris‐ HA c. Although no significant differences in the rate of apatite formation were observed during the time points studied here (6 hours to 7 days), the presence of chloride ions may affect very early stages of apatite formation. It may therefore be advantageous to use modified Tris buffer solutions, which do not contain high concentrations of ions involved in apatite formation, when studying early time point release kinetics or apatite precipitation of bioactive glasses.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Facial Trauma and Fracture Management · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Otto Schott Institute of Materials Research Friedrich Schiller University Jena Germany

Institute of Applied Physics Friedrich Schiller University Jena Germany

References (52)

Show source-provided references
1. 10.1002/jbm.82005061110.1002/jbm.820050611 ↗
2. Bioglass®: a short history and bibliography
3. 10.1111/ijag.1225210.1111/ijag.12252 ↗
4. Clinical evaluation of a dentifrice containing calcium sodium phosphosilicate (NovaMin) for the treatment of dentin hypersensitivity
5. 10.1016/j.dental.2011.11.02110.1016/j.dental.2011.11.021 ↗
6. 10.1016/j.jdent.2010.09.00410.1016/j.jdent.2010.09.004 ↗
7. 10.1016/j.jdent.2007.12.00410.1016/j.jdent.2007.12.004 ↗
8. 10.1111/j.1600-0722.2008.00561.x10.1111/j.1600-0722.2008.00561.x ↗
9. 10.1016/j.biomaterials.2011.01.00410.1016/j.biomaterials.2011.01.004 ↗
10. 10.1002/anie.20140531010.1002/anie.201405310 ↗
11. 10.1073/pnas.141979911210.1073/pnas.1419799112 ↗
12. 10.1007/s10853-017-0838-710.1007/s10853-017-0838-7 ↗
13. 10.1039/c0jm01111h10.1039/c0jm01111h ↗
14. 10.1007/s10856-015-5403-910.1007/s10856-015-5403-9 ↗
15. 10.1016/j.biomaterials.2010.01.12110.1016/j.biomaterials.2010.01.121 ↗
16. 10.1002/jbm.a.3472410.1002/jbm.a.34724 ↗
17. 10.1016/j.actbio.2012.10.04310.1016/j.actbio.2012.10.043 ↗
18. 10.1016/j.actbio.2012.08.05110.1016/j.actbio.2012.08.051 ↗
19. 10.1039/C5TB02426A10.1039/C5TB02426A ↗
20. 10.1098/rsif.2011.038710.1098/rsif.2011.0387 ↗
21. 10.1111/j.1551-2916.2012.05374.x10.1111/j.1551-2916.2012.05374.x ↗
22. Ionization constants and heats of tris(hydroxymethyl)aminomethane and phosphate buffers10.1016/S0021-9258(18)65858-2 ↗
23. 10.1016/j.matlet.2014.12.12410.1016/j.matlet.2014.12.124 ↗
24. 10.1016/j.jnoncrysol.2011.05.03110.1016/j.jnoncrysol.2011.05.031 ↗
25. 10.1515/bglass-2016-001210.1515/bglass-2016-0012 ↗
26. Elliott JC · 1994
27. 10.1016/j.jnoncrysol.2013.05.03910.1016/j.jnoncrysol.2013.05.039 ↗
28. 10.1016/S0109-5641(02)00106-910.1016/S0109-5641(02)00106-9 ↗
29. 10.1023/A:102117491280210.1023/A:1021174912802 ↗
30. 10.1002/jbm.1005310.1002/jbm.10053 ↗
31. 10.1007/BF0190385610.1007/BF01903856 ↗
32. 10.1016/j.actbio.2010.01.04310.1016/j.actbio.2010.01.043 ↗
33. 10.1007/s10856-009-3732-210.1007/s10856-009-3732-2 ↗
34. 10.1016/j.actbio.2005.12.00310.1016/j.actbio.2005.12.003 ↗
35. 10.1016/j.actbio.2008.04.01910.1016/j.actbio.2008.04.019 ↗
36. 10.1016/j.actbio.2012.08.02310.1016/j.actbio.2012.08.023 ↗
37. 10.1023/A:102110652509710.1023/A:1021106525097 ↗
38. 10.1002/jbm.a.3221310.1002/jbm.a.32213 ↗
39. 10.2138/rmg.2002.48.1110.2138/rmg.2002.48.11 ↗
40. 10.1002/jbm.82025080810.1002/jbm.820250808 ↗
41. 10.1007/s10856-008-3661-510.1007/s10856-008-3661-5 ↗
42. 10.1039/B414143A10.1039/B414143A ↗
43. 10.1016/j.msec.2005.01.00810.1016/j.msec.2005.01.008 ↗
44. 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-110.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
45. 10.2138/am.2010.316810.2138/am.2010.3168 ↗
46. 10.1177/0895937487001002220110.1177/08959374870010022201 ↗
47. 10.1038/1961048b010.1038/1961048b0 ↗
48. 10.1016/j.jnoncrysol.2016.11.01810.1016/j.jnoncrysol.2016.11.018 ↗
49. 10.1139/v79-30710.1139/v79-307 ↗
50. 10.1016/j.actbio.2010.11.03710.1016/j.actbio.2010.11.037 ↗
51. 10.4028/www.scientific.net/KEM.284-286.48110.4028/www.scientific.net/KEM.284-286.481 ↗
52. 10.1016/0022-3093(90)90247-J10.1016/0022-3093(90)90247-J ↗